DocuSign (DOCU.US) Price Target and Rating 2026/2027

56,53
-1,67%
Price history for DocuSign (DOCU.US) – stock price at 56.53 $, August 2026
DocuSign stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

DocuSign Price Target 2026: Analysts See 5% Upside

The average price target for DocuSign is $59.33. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 4,95% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is DocuSign overvalued or undervalued?

DocuSign is currently fairly valued with a gap of 5% relative to the price target.


The current price is $56.53, which places DocuSign in the fairly valued category. The stock is considered undervalued when the price is below $53.40, and overvalued when the price exceeds $65.26.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For DocuSign, the fair value range lies between $53.40 and $65.26.


See the full price target analysis for DocuSign →

Analyst Ratings for DocuSign stock in 2026: Hold

23 analysts cover DocuSign. Analysts are mostly neutral — 69.6% recommend Hold. The average price target is $59.33, which gives an upside of 5% from the current price.

Consensus: Hold (3.30/5)
Strong Buy
3 (13%)
Buy
3 (13%)
Hold
16 (69.6%)
Strong Sell
1 (4.3%)
Strong Sell Sell Hold Buy Strong Buy
3.30 out of 5 based on 23 analysts

About DocuSign – Software - Application

docu.us leverer software, der gør det muligt for virksomheder at håndtere aftaler digitalt. De tjener primært penge på deres e-signaturløsning, som lader kunder forberede, underskrive og styre dokumenter. Virksomheden udvikler også mere avancerede værktøjer. For eksempel har de CLM, der automatiserer hele aftaleprocessen, og Insights, som bruger AI til at analysere juridiske klausuler i aftaler. De sælger også specialløsninger som Gen for Salesforce, der automatisk laver aftaler direkte i kundens salgssystem. docu.us startede i 2003 og har siden udbredt deres løsninger internationalt. De har også Click, der understøtter standardaftaler uden krav om underskrift. Read more about the company

Key Figures for DocuSign

$ 11,0B Market cap
$ 3,3B Revenue
Software - Application Industry
37.36 P/E
3.34 P/S
5.75 P/B
USA Listed on exchange

What kind of stock is DocuSign?

Growth stock

DocuSign is classified as a growth stock with quarterly earnings growth of 17.6% and strong long-term momentum of 0.0%.

Score Overview for DocuSign

💰 Value Score 35/100 (Low)
⭐ Quality Score 52/100 (Neutral)
🚀 Momentum Score 39/100 (Low)
📊 Total Score 42/100

⚠️ 2 red flags identified 1 critical

Our analysis has identified 2 potential risk factors in DocuSign that investors should be aware of.

🚨 Weak balance sheet (elevated risk): Altman Z2 is -1.21 – the balance sheet is measurably weaker than average. This is a risk signal based on the numbers, not a bankruptcy prediction.
⚠️ High short interest: 11.6% of the shares are sold short – many professional investors are betting on price declines.

📈 Valuation

DocuSign trades at a P/E ratio of 37.4, which is above the market average. The forward P/E is 12.0 (68% lower), which suggests the market expects rising earnings. The P/S ratio is 3.3. The P/B ratio is 5.8. The PEG ratio is 0.65 — below 1.0 suggests the stock is cheap relative to its growth rate.

💵 Profitability & Growth

DocuSign has a profit margin of 9.6% (moderate) and an operating margin of 13.4%. Return on equity (ROE) is 16.4% — solid return on equity. Return on assets (ROA) is 5.5%. The latest quarterly earnings grew 17.6% year over year.

🏦 Financial Health

The Piotroski score is 6 out of 9 — good financial health. Altman Z2 is -1.21 (weak balance sheet — elevated risk). The debt-to-equity ratio (D/E) is 100.4% — moderate debt.

🚀 Momentum & Short Interest

Short interest is 11.59% — very high, the market is skeptical.

Insider Trading in DocuSign 2026: The Signal Is negative

In 2026, insiders at DocuSign have made 20 transactions – split into 3 purchases and 17 sales. On a net basis, insiders took 5,039,517 $ out of the stock. Active insiders include Hansen Paula, GRAYSON BLAKE JEFFREY, Chatwani Robert and others. In the short term (last 3 months), the insider signal is negative.

Short-Term Signal (3 months): Negative

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 9 sales. A net 2,173,205 $ out of the stock.

Long-Term Signal (all transactions): Mostly negative

Insiders have sold considerably more than they have bought. At large companies this can be due to planned sales (10b5-1 plans) and is not necessarily a negative signal.

Across the last 20 transactions: 3 purchases and 17 sales. A net 5,039,517 $ out of the stock.

Latest purchase: Hansen Paula bought 346 shares at 41 $ each on 2026-04-03. The stock has since risen 39.8%.

Latest sale: Thygesen Allan C. sold 4,257 shares at 46 $ each on 2026-07-01.

Who is buying: Hansen Paula, GRAYSON BLAKE JEFFREY, Chatwani Robert.

Who is selling: Thygesen Allan C., Shaughnessy James P, Hansen Paula, GRAYSON BLAKE JEFFREY, Chatwani Robert and others.

Latest Insider Trades in DocuSign (2026)

The table shows the last 20 reported insider transactions in DocuSign. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-07-01 Thygesen Allan C. Sell 4,257 46 196,290
2026-07-01 Shaughnessy James P Sell 11,754 46 540,802
2026-07-01 Hansen Paula Sell 6,000 46 273,240
2026-07-01 GRAYSON BLAKE JEFFREY Sell 14,400 46 662,256
2026-06-22 Chatwani Robert Sell 9,222 44 401,341
2026-06-05 Marrs Anna Sell 363 49 17,939
2026-06-02 Marrs Anna Sell 365 55 20,090
2026-06-02 BEER JAMES A Sell 450 55 24,768
2026-05-29 Briggs Teresa Sell 729 50 36,479
2026-04-03 Hansen Paula Buy 346 41 14,224

Who is buying and selling DocuSign shares in 2026?

The following insiders have bought shares in DocuSign: Hansen Paula, GRAYSON BLAKE JEFFREY, Chatwani Robert. In total, 38,931 $ was bought across 3 transactions. The following insiders have sold shares: Thygesen Allan C., Shaughnessy James P, Hansen Paula, GRAYSON BLAKE JEFFREY, Chatwani Robert and others. In total, 5,078,448 $ was sold across 17 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

DocuSign Short Selling 2026: 11.6% Sold Short

Very high short interest: 11.6% of the free float
Short % of free float
11.6%
Assessment
Very high short interest
Short squeeze risk
High
Data source
SEC
Updated daily
The stock has a very high share of short selling. Between 10-20% of the freely traded shares are sold short, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains.

What does this mean for you as an investor?
A short interest of 11.6% means that 11.6% of the freely traded shares in DocuSign have been borrowed and sold by investors betting on falling prices. On positive surprises (e.g. a strong earnings report), short sellers can be forced to buy back shares quickly to close their positions, which can cause a short squeeze with sharp price gains in a short time.

The next potential catalyst is the earnings report on 9/3/2026. With a short interest of 11.6%, the report can trigger considerable volatility.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
11.6%

When Does DocuSign Report Earnings – Next Date: 9/3/2026

The next earnings report from DocuSign is scheduled for September 3, 2026, after the market closes. This report covers the third quarter (Q3), which ended on July 31, 2026.



Technical Analysis of DocuSign 2026 – Signal: Buy

Overall Technical Signal: Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of DocuSign (DOCU.US) – RSI 65, MACD positive (bullish), daily candlestick chart August 2026
DocuSign technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of DocuSign, Inc

DocuSign, Inc is in a short-term uptrend. The price of $57.49 is 9.6% above the 20-day average ($52.46). Medium term, the picture is positive: the price is 17.2% above the 50-day average ($49.05). Long term, the stock is 5.5% above the 200-day average ($54.51), which confirms a long-term uptrend.

Death Cross: The 50-day average (49.05) is below the 200-day average (54.51), which is a classic bearish signal for DocuSign, Inc.

Is DocuSign, Inc overbought or oversold?

DocuSign, Inc has an RSI of 64.6. The stock shows positive momentum in the upper part of the neutral zone. Combined with the positive trend, this supports the bullish picture.

MACD Analysis for DocuSign, Inc

Daily MACD: MACD is positive (2.439), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (1.937) by 0.502, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is negative (-1.546), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-3.525) by 1.979, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: The daily and weekly MACD give conflicting signals. The short-term trend is bullish, but the long-term trend is still bearish. Weekly momentum is rising, though, which could signal an upcoming trend reversal.

Risk Profile for DocuSign, Inc

DocuSign, Inc has an annual standard deviation of 47.7%, which classifies the stock as high risk. Sizeable price swings are normal, and the stock requires a higher risk tolerance.

Overall Technical Conclusion for DocuSign, Inc

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (2.439). Weekly bearish (-1.546).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 64.6 – neutral.

Technical signal: Buy

The broader trend is positive and MACD supports the picture. Consider buying with a stop-loss below the nearest support level.

Frequently Asked Questions About DocuSign stock in 2026

Should you buy DocuSign stock now?
Yes, the technical signal for DocuSign is currently BUY. DocuSign trades at $56.53 as of 8/6/2026. The overall technical signal is: Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 2.439 with rising momentum (signal: 1.937); RSI is at 64.6 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $59.33 points to 5.0% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for DocuSign stock?
The average analyst price target for DocuSign is $59.33. The current price is $56.53, which gives an upside of 5.0%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $53.40 and $65.26.
Is DocuSign a dividend stock?
No, DocuSign does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of DocuSign stock?
DocuSign is rated as a stock with high risk. the annual standard deviation is 47.7%, which classifies the stock as high risk.
Is DocuSign overvalued?
DocuSign is considered fairly valued – the price is close to the analyst price target. DocuSign has the following valuation ratios: a P/E ratio of 37.4 (highly valued), a P/S ratio of 3.3, a P/B ratio of 5.8. The stock trades close to the analyst price target and is considered fairly valued.
Is DocuSign overbought?
No, DocuSign is not overbought. RSI is at 64.6 (neutral zone). The technical indicators show: RSI is at 64.6 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 7.8% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next DocuSign earnings report?
DocuSign reports its next earnings on September 3, 2026. The stock currently trades at $56.53. With a P/E ratio of 37.4, the market will be watching closely whether earnings meet expectations.
Is DocuSign shorted?
Yes, DocuSign is shorted with 11.6% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying DocuSign stock?
No, insiders are not buying DocuSign shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 9 sales. On a net basis, 2,173,205 $ worth of shares were sold. Across the last 20 reported transactions, the split is 3 purchases and 17 sales, with a net 5,039,517 $ sold. Active sellers include Thygesen Allan C., Shaughnessy James P, Hansen Paula and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is DocuSign a good stock?
Based on our total score, DocuSign is rated as a mediocre stock with a total score of 42 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 35/100, Quality: 52/100, Momentum: 39/100. In addition: technical signal: Buy. Whether DocuSign is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for DocuSign stock?
The outlook for DocuSign based on current data: the average analyst price target is $59.33 (+5.0%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on 9/3/2026, which can move the price; the P/E ratio is 37.4 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is DocuSign stock rising?
DocuSign is rising right now. The technical indicators show: the price is 7.8% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 11.6% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can DocuSign go?
The average analyst price target for DocuSign is $59.33, which corresponds to a potential gain of 5.0% from the current price of $56.53. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can DocuSign fall?
We lack enough history to give a specific floor for DocuSign. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does DocuSign do?
docu.us leverer software, der gør det muligt for virksomheder at håndtere aftaler digitalt. De tjener primært penge på deres e-signaturløsning, som lader kunder forberede, underskrive og styre dokumenter. Virksomheden udvikler også mere avancerede værktøjer. For eksempel har ... The company belongs to the Teknologi sector, more specifically the Software - Application industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate DocuSign as an investment.
Did DocuSign raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from DocuSign. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is DocuSign making money or losing money?
Yes, DocuSign is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 9.6% — which is moderate. The operating margin (profit before interest and taxes) is 13.4%. At a P/E ratio of 37.4, you currently pay 37.4 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can DocuSign go bankrupt?
The bankruptcy risk of DocuSign is rated as elevated. Altman Z2 (a model for assessing financial distress) is -1.21 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 100% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does DocuSign have a lot of debt?
DocuSign has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 100%. For the teknologi sector, 80-150% counts as a typical level. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can DocuSign service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 214.7x, and the company has more cash than debt (net cash).